An International “DNA Cytometry Consensus Conference” was held in October 1992, in Maine (USA): The Author reports the opinions concerning bladder tumours, expressed by the experts at the Conference. Models for future studies with Flow Cytometry are also reported.
AamodtR.L.CoonJ.S.DeitchA.: Flow cytometric evaluation of bladder cancer: recommendations of the NCI flow cytometry network for bladder cancer. World J. Urol., 10: 63–67, 1992.
2.
GiarettiW.: Ploidy and proliferation evaluated by flow cytometry. An overview of techniques and impact in oncology. Tumori, 77: 403–419, 1991.
3.
BadalamentR.A.FairW.R.WhitmoreW.F.Jr., and MelamedM.R.: The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. Sem. Urol., 6: 22–30, 1988.
4.
BadalamentR.A.GayH.WhitmoreW.F.Jr.: Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry. Cancer, 58: 2751–2757, 1986.
5.
BadalamentR.A.HermansenD.K.KimmelM.: The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer, 60: 1423–1427, 1987.
6.
BadalamentR.A.KimmelM.GayH.: The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer, 59: 2078–2085, 1987.
7.
deVere WhiteR.W.OlssonC.A., and DeitchA.D.: Flow cytometry: role in monitoring transitional cell carcinoma of bladder. Urol., 28: 15–20, 1986.
8.
GiellaJ.G.RingK.OlssonC.A.KarpF.S., and BensonM.C.: The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder. J. Urol., 148: 293–296, 1992.
9.
HermansenD.K.BadalamentR.A.FairW.R.KimmelM.WhitmoreW.F.Jr.MelamedM.R.: Detection of bladder carcinoma in females by flow cytometry and cytology. Cytometry, 10: 739–742, 1989.
10.
KleinF.A.WhiteF.K.: Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience. J. Urol., 139: 275–278, 1988.
11.
KonchubaA.M.SchellhammerP.F.AlexanderJ.P.WrightG.L.Jr.: Flow cytometric study comparing paired washing and voided urine for bladder cancer detection. Urol., 33: 89–96, 1989.
12.
BlomjousC.E.SchipperN.W.BaakJ.P.van GalenE.M.de VoogtH.J.MeyerC.J.: Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J. Clin. Pathol., 41: 21–25, 1988.
13.
BlomjousC.E.SchipperN.W.BaakJ.P.VosW.de VoogtH.J.MeyerC.J.: The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am. J. Clin. Pathol., 91: 243–248, 1989.
14.
de VereR.W.DeitchA.D.WestB.FitzpatrikJ.M.: The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer. J. Urol., 139: 279–282, 1988.
15.
FradetY.TardifM.BourgetL.RobertJ.: Clinical cancer progression in urinary bladder tumours evaluated by multiparameter flow cytometric with monoclonal antibodies. Laval University Urology Group. Cancer Res., 50: 432–437, 1990.
16.
GustafsonH.TribukaitB.: Characterization of bladder carcinomas by flow DNA analysis. Europ. Urol., 11: 410–417, 1985.
17.
GustafsonH.TribukaitB.EspostiP.L.: DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand. J. Urol. Nephrol., 16: 135–139, 1982.
18.
GustafsonH.TribukaitB.EspostiP.L.: DNA profile and tumour progression in patients with superficial bladder tumours. Urol. Res., 10: 13–18, 1982.
19.
GustafsonH.WijkstromH.NymanC.BrolinJ.BorgstromE.TribukaitB.: Prophylactic instillation therapy of superficial bladder cancer. Scand. J. Urol. Nephrol., Suppl.138: 187–191, 1992.
20.
NormingU.TribukaitB.GustafsonH.NymanC.R.WangN.N.WijkstromH.: Deoxyribonucleic acid profile and tumour progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. J. Urol., 147: 11–15, 1992.
21.
NormingU.TribukaitB.NymanC.R.NilssonB.WangN.N.: Prognostic significance of mucosal aneuploidy in the stage Ta/T1 Grade 3 carcinoma of the bladder. J. Urol., 148: 1420–1427, 1990.
22.
GiarettiW.SantiL.: Tumour progression by DNA flow cytometry in human colorectal cancer. Int. J. Cancer, 45: 597–603, 1990.
23.
GiarettiW.: A model on the origin and evolution of DNA aneuploidy. Int. J. Oncol., 2: 165–171, 1993.
